This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included but will usually appear in 24 hrs or less.

Rational Source
The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent. βœ…
Antibiotics (Basel, Switzerland) (Antibiotics (Basel) ) Vol: 10 Issue 6 Pages:
Pub: 2021 May 29 Epub: 2021 May 29 Authors Ridyard KE , Overhage J ,
The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent. βœ…
Antibiotics (Basel, Switzerland) (Antibiotics (Basel) ) Vol: 10 Issue 6 Pages:
Pub: 2021 May 29 Epub: 2021 May 29 Authors Ridyard KE , Overhage J ,
The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent. βœ…
Antibiotics (Basel, Switzerland) (Antibiotics (Basel) ) Vol: 10 Issue 6 Pages:
Pub: 2021 May 29 Epub: 2021 May 29 Authors Ridyard KE , Overhage J ,
The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent. βœ…
Antibiotics (Basel, Switzerland) (Antibiotics (Basel) ) Vol: 10 Issue 6 Pages:
Pub: 2021 May 29 Epub: 2021 May 29 Authors Ridyard KE , Overhage J ,
The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent. βœ…
Antibiotics (Basel, Switzerland) (Antibiotics (Basel) ) Vol: 10 Issue 6 Pages:
Pub: 2021 May 29 Epub: 2021 May 29 Authors Ridyard KE , Overhage J ,
The collectin SP-A and its trimeric recombinant fragment protect alveolar epithelial cells from the cytotoxic and proinflammatory effects of human cathelicidin in vitro. βœ… Go to Publication βœ…
Frontiers in immunology (Front Immunol ) Vol: 13 Issue Pages: 994328
Pub: 2022 Epub: 2022 Aug 29 Authors de Tapia L , García-Fojeda B , Kronqvist N , Johansson J , Casals C ,
The collectin SP-A and its trimeric recombinant fragment protect alveolar epithelial cells from the cytotoxic and proinflammatory effects of human cathelicidin in vitro. βœ… Go to Publication βœ…
Frontiers in immunology (Front Immunol ) Vol: 13 Issue Pages: 994328
Pub: 2022 Epub: 2022 Aug 29 Authors de Tapia L , García-Fojeda B , Kronqvist N , Johansson J , Casals C ,
In vitro activity of the antimicrobial peptides h-Lf1-11, MSI-78, LL-37, fengycin 2B, and magainin-2 against clinically important bacteria. βœ… Go to Publication βœ…
Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] (Braz J Microbiol ) Vol: 53 Issue 1 Pages: 171-177
Pub: 2022 Mar Epub: 2021 Nov 4 Authors Denardi LB , de Arruda Trindade P , Weiblen C , Ianiski LB , Stibbe PC , Pinto SC , Santurio JM ,
In vitro activity of the antimicrobial peptides h-Lf1-11, MSI-78, LL-37, fengycin 2B, and magainin-2 against clinically important bacteria. βœ… Go to Publication βœ…
Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] (Braz J Microbiol ) Vol: 53 Issue 1 Pages: 171-177
Pub: 2022 Mar Epub: 2021 Nov 4 Authors Denardi LB , de Arruda Trindade P , Weiblen C , Ianiski LB , Stibbe PC , Pinto SC , Santurio JM ,
In vitro activity of the antimicrobial peptides h-Lf1-11, MSI-78, LL-37, fengycin 2B, and magainin-2 against clinically important bacteria. βœ… Go to Publication βœ…
Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] (Braz J Microbiol ) Vol: 53 Issue 1 Pages: 171-177
Pub: 2022 Mar Epub: 2021 Nov 4 Authors Denardi LB , de Arruda Trindade P , Weiblen C , Ianiski LB , Stibbe PC , Pinto SC , Santurio JM ,
In vitro activity of the antimicrobial peptides h-Lf1-11, MSI-78, LL-37, fengycin 2B, and magainin-2 against clinically important bacteria. βœ… Go to Publication βœ…
Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] (Braz J Microbiol ) Vol: 53 Issue 1 Pages: 171-177
Pub: 2022 Mar Epub: 2021 Nov 4 Authors Denardi LB , de Arruda Trindade P , Weiblen C , Ianiski LB , Stibbe PC , Pinto SC , Santurio JM ,
The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections. βœ… Go to Publication βœ…
BMC infectious diseases (BMC Infect Dis ) Vol: 18 Issue 1 Pages: 17
Pub: 2018 Jan 8 Epub: 2018 Jan 8 Authors Babikir IH , Abugroun EA , Bilal NE , Alghasham AA , Abdalla EE , Adam I ,
The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. βœ…
Science translational medicine (Sci Transl Med ) Vol: 10 Issue 423 Pages:
Pub: 2018 Jan 10 Epub: Authors de Breij A , Riool M , Cordfunke RA , Malanovic N , de Boer L , Koning RI , Ravensbergen E , Franken M , van der Heijde T , Boekema BK , Kwakman PHS , Kamp N , El Ghalbzouri A , Lohner K , Zaat SAJ , Drijfhout JW , Nibbering PH ,
The activity and action mechanism of novel short selective LL-37-derived anticancer peptides against clinical isolates of Escherichia coli. βœ… Go to Publication βœ…
Chemical biology & drug design (Chem Biol Drug Des ) Vol: 93 Issue 1 Pages: 75-83
Pub: 2019 Jan Epub: 2018 Oct 3 Authors Aghazadeh H , Memariani H , Ranjbar R , Pooshang Bagheri K ,

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]